美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HORIZON KINETICS MEDICAL ETF

34.96

-0.3314-0.94%

盤後：35.040.0823+0.24%16:10 EDT

成交量：588

成交額：2.06萬

市值：1,642.82萬

市盈率：- -

高：35.04

開：34.99

低：34.96

收：35.29

52周最高：37.90

52周最低：28.87

股本：46.99萬

流通股本：46.99萬

量比：0.27

換手率：0.13%

股息：0.41

股息率：1.17%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

放量普跌！有色突遭重挫，創新藥跌跌不休！光模塊逆市獨漲，高「光」創業板人工智能ETF（159363）V型拉升

貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證

東方生物：獲得多項境外醫療器械註冊證

九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證

麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂

昂利康創新藥引進項目告吹：授權合作折戟背後，主業承壓研發布局遇變數

一品紅痛風創新藥Ⅲ期臨床達到主要終點大中華區銷售峯值預計達19.5億元

無AI增長：八大精選股票

港股異動 | 創新藥概念股持續調整海外利率預期反覆 2026國談收官進入結果等待期

百龍創園在昆明成立生物科技公司

港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行

涉IPO操縱嫌疑，香港證監會強制眼科創新藥公司撥康視雲停牌，最牛天使投資人富豪龔虹嘉是站台的基石投資者

國產創新藥新適應症密集獲批「一藥拓多域」重塑行業成長邏輯

國產創新藥新適應症密集獲批「一藥拓多域」重塑行業成長邏輯

第七批國家組織醫用耗材集中採購開標；諾華大股東呼籲改組董事會｜醫藥早參

每日经济新闻

媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社

重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標

強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/MEDX/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9577,"timestamp":1789502400000,"preClose":35.2891,"halted":0,"volume":588,"hourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"delay":0,"changeRate":-0.009391001754082565,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未開盤","change":-0.3314,"latestTime":"09-15 16:00:00 EDT","open":34.99,"high":35.04,"low":34.9577,"amount":20606,"amplitude":0.002332,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":35.2891,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.0117,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"volumeRatio":0.26793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.26793,"shares":469946,"dividePrice":0.409,"high":35.04,"amplitude":0.002332,"preClose":35.2891,"low":34.9577,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9577,"eps":0,"divideRate":0.0117,"volume":588,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.4213,"twentyDayClose":35.8903,"sixtyDayClose":33.8763},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666452917","title":"放量普跌！有色突遭重挫，創新藥跌跌不休！光模塊逆市獨漲，高「光」創業板人工智能ETF（159363）V型拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666452917","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666452917?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:15","pubTimestamp":1789125300,"startTime":"0","endTime":"0","summary":"有色板块领跌全市场，揽尽有色金属行业龙头的有色ETF华宝标的指数收跌4.04%失守所有均线。FCC政策落地，光通信担忧明显缓解，光模块龙头逆市走强，中际旭创逆市收涨4%，新易盛涨近3%，高“光”创业板人工智能ETF华宝标的指数日内“V”型拉升。中际旭创、新易盛逆市上涨，高“光”指数V型拉升！*布局高“光”主线+AI应用，建议关注创业板人工智能ETF华宝及场外联接，重点布局光模块CPO龙头，兼顾AI应用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrq6694331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX","159876","000001.SH","MVPS","LNGR","KOMP","LUMA","159982","AGIX","FDN","DQJN","TECY","06978","AQGX","399300","AIQU","QSWN","CPNQ","159363","161631","515890","159915","AAOZ","399006","512510","QTOC","ARTY","CHAT","WPAI","LYTE","OGIG","AIFD","FWD","QQA","510300","TARK","MFIG","NBDS","CWC","NEWZ","GK","IBBQ","LCLG","CNXT","PBOT","AIBU","159992","VUSE","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525651","title":"貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525651?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","RSPH","HART","MDEV","LGHT","AGNG","LNGR","IEIH","MEDX","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666230575","title":"東方生物：獲得多項境外醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666230575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666230575?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:05","pubTimestamp":1789121126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","AGNG","GDOC","LGHT","PTH","RSPH","HART","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544799","title":"九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544799?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:50","pubTimestamp":1789113020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LNGR","IEIH","LGHT","MDEV","PTH","HART","GDOC","MEDX","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1583","HART","LNGR","XMMO","RSPH","BK1100","BK1574","GDOC","LGHT","CALF","BK4585","IEIH","PTH","AGNG","02041","KCE","BK4588","MDEV","MEDX","159883","MYLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544925","title":"昂利康創新藥引進項目告吹：授權合作折戟背後，主業承壓研發布局遇變數","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544925","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544925?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"9 月 6 日，昂利康发布公告宣布终止与亚飞生物、亲合力的 IMD\u001e1005肿瘤抗体药物授权许可合作。02主业盈利出现下滑，创新转型面临双重考验创新药引进受挫的同时，昂利康主业经营已经显现压力。原料药业务是昂利康的基本盘，业绩下滑说明核心主业易受行业周期、市场供需波动冲击，自身抗周期能力有待加强。未来昂利康既要稳固原料药基本盘，也需要平衡好资金投入与管线风险，审慎推进授权引进类项目。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5384750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","159992","MEDX","IBBQ","BK1161","LNGR","002940","BK0239","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544603","title":"一品紅痛風創新藥Ⅲ期臨床達到主要終點 大中華區銷售峯值預計達19.5億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544603","media":"新浪证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:34","pubTimestamp":1789112040,"startTime":"0","endTime":"0","summary":"近日，一品红自愿披露关于痛风创新药AR882治疗痛风伴高尿酸血症患者Ⅲ期临床研究达到主要终点的公告。商业化权益方面，AR882为一品红自主研发的1类创新药，在大中华区拥有完整的开发、生产与商业化权益，且一品红具备成熟的自有慢病药商业化团队，无需对外支付销售分成。结合0.70的临床成功概率，最终AR882大中华区痛风适应症管线的风险调整净现值约为5.5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-11/doc-inirmvzz2155509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","IBBQ","MEDX","300723","06978","BK0239","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114311100","title":"無AI增長：八大精選股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1114311100","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114311100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:06","pubTimestamp":1789103219,"startTime":"0","endTime":"0","summary":"人工智能究竟是一场第四次工业革命，还是一个超级泡沫？答案取决于你听的是华尔街哪位预言家的高论。它或将开启一个超级生产力周期，或将引发崩盘——亦或是两者兼而有之。它将攻克疾病与贫困，除非它先降低了大规模毁灭的门槛。有时实在令人疲惫不堪。以下八只颇具前景的股票，幸运地与AI关联甚微。没有事件视界，我们有的是一场盛大的电子游戏发布。我们不敢保证这份名单100%与AI绝缘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","LU2112291526.USD","LU2746668974.SGD","BK4517","LU2111349929.HKD","BK4142","BK4566","FTXH","SG9999014005.SGD","LU0234572021.USD","LU2265009873.SGD","LU1868836914.USD","SGXZ57979304.SGD","IE00B775H168.HKD","LU1983299246.USD","LU2602419157.SGD","LU1979441026.SGD","LU2552382058.USD","LU0471298694.HKD","IE00BJJMRY28.SGD","LU0158827948.USD","OZEM","SG9999014021.USD","LU2271345857.HKD","LU0174119429.USD","LU0320765992.SGD","IE00BKPKM429.USD","AGNG","LU2264538146.SGD","RCL","WDNA","IE00B4JS1V06.HKD","BK4127","THNR","LU2168564149.EUR","LU1057294990.SGD","LU0345774631.USD","SG9999014880.SGD","LU0256863811.USD","LU1670627923.USD","LU1551013425.SGD","LU0109391861.USD","LU1989771016.USD","LU0354030438.USD","LU2237443895.HKD","LU2417539215.USD","LU0310800379.SGD","LU2491050154.USD","LU0106831901.USD","LLYZ","LU1712237335.SGD","LU0980610538.SGD","LU2462157665.USD","LU0006306889.USD","LU1623119135.USD","LU0306806265.USD","SGXZ31699556.SGD","LU2106854487.HKD","LU1861217088.USD","LU0353189680.USD","LU0109394709.USD","LU1323610961.USD","LU2468319806.SGD","SG9999013999.USD","BK4200","LU2168564495.EUR","LU2552382132.HKD","LU0820561909.HKD","SG9999015978.USD","SWK","LU2023250504.SGD","LU1291159041.SGD","BK4534","LLY","LU1629891620.HKD","LU1974910355.USD","LU0061475181.USD","LU0385154629.USD","LU1145028129.USD","IHE","LU2361044949.HKD","IE00BK4W5L77.USD","LU2237443978.SGD","IE0002270589.USD","LU1280957306.USD","LU1868836591.USD","LU0964807845.USD","BK4504","LU1093756168.USD","CANC","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU2087625088.SGD","LU0882574139.USD","LU0354030511.USD","LU1267930573.SGD","LU1074936037.SGD","LU0251142724.SGD","LU1720051017.SGD","LU2750360641.GBP","LU2213496289.HKD","VHT","LU2456880835.USD","LU2023250330.USD","LU0477156953.USD","SG9999001176.SGD","LU2462591350.SGD","LLII","WNDR","LU0097036916.USD","IE00B4R5TH58.HKD","LU0708994859.HKD","RXL","LU0882574055.USD","LU0787776722.HKD","LU1363072403.SGD","IE00BN29S564.USD","MEDX","LU0742534661.SGD","LU0820561818.USD","LU2471134879.HKD","LU2360107671.USD","LU2028103732.USD","LU2491049909.HKD","SG9999014914.USD","BK4516","BK4589","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1861220207.SGD","LU0456855351.SGD","LU0466842654.USD","LU0345774391.USD","LU2896262040.SGD","LU2089283258.USD","FHLC","LU1670628061.USD","LU2168563687.JPY","LU0820562030.AUD","LU2361045086.USD","IE00B1BXHZ80.USD","LU0689472784.USD","LU0210536198.USD","LU0971096721.USD","LU0306807586.USD","SG9999015986.USD","ELIS","GB00BDT5M118.USD","SG9999014906.USD","LU0130102774.USD","LU0323591593.USD","LU1691799644.USD","LLYX","LU1791807156.HKD","SG9999001077.SGD","LU0471298777.SGD","LU0985481810.HKD","LU1668664300.SGD","LU0640476718.USD","IE00BWXC8680.SGD","BK4599","LU1035775433.USD","SG9999014039.USD","LU0133085943.USD","LU0128525929.USD","LU2357305700.SGD","LU2089984988.USD","LU2237443382.USD","SG9999001176.USD","LU1551013342.USD","GDOC","LU2237438978.USD","LU0417517546.SGD","XLV","LU2089284900.SGD","LU0029864427.USD","LU0316494557.USD","LU0011850046.USD","LU0251131958.USD","BK4581","LU2471134796.USD","LU1064131342.USD","LU0345770308.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0225771236.USD","LU1201861249.SGD","LU0094547139.USD","LU1868837136.USD","FIVE","LU0079474960.USD","LU0114720955.EUR","SG9999015952.SGD","SG9999014898.SGD","LU0203201768.USD","LU2237443622.USD","BMRN","LU0320765059.SGD","IE00BFSS7M15.SGD","SGXZ99366536.SGD","LU0266013472.USD","IYH","IAI","IE00B7KXQ091.USD","LU2491050071.SGD","LU2471134952.CNY","LU0289739699.SGD","HRTS","LU2360106947.USD","LU2461242641.AUD","LU2168564065.EUR","IE00BJT1NW94.SGD","LU1127390331.HKD","LU0683600562.USD","LU2746668461.USD","IXJ","IE0004445239.USD","BK4585","LU1868837300.USD","LU2063271972.USD","LU0648001328.SGD","LU0198837287.USD","SG9999018865.SGD","IE00B7SZLL34.SGD","LU2023251221.USD","LU0048573561.USD","IE0005OL40V9.USD","MHIP","LU1035773651.USD","LU1917777945.USD","LU2750360997.AUD","PJP","LU0823416689.USD","LU1069347547.HKD","LU2237443549.SGD","IE000M9KFDE8.USD","LU0238689110.USD","LU2237443465.HKD","LU1267930730.SGD","ILDR","LU2108987350.USD","LU0943347566.SGD","LU1153585028.USD","IE0001KFT4U8.USD","LU0672654240.SGD","LU1720051108.HKD","LU1023059063.AUD","LU0130517989.USD","LU1548497426.USD","LU0122379950.USD","LU0432979614.USD","SCHW","LU2324357040.USD","LU1069344957.HKD","BK4533","LU0225283273.USD","LU1366192091.USD","LU2168564222.USD","IE00BJJMRX11.SGD","CURE","ELIL","TMED","SGXZ81514606.USD","LU0823434583.USD","LU1061106388.HKD","LU0256863902.USD","BK4588","BK4007","PPH","MEDI","JDOC","LU0158827781.USD","LU0353189763.USD","IE00BKDWB100.SGD","LU0321505439.SGD","SG9999015945.SGD","LU2236285917.USD","LU0096364046.USD","IE00B2B36J28.USD","LU2211815571.USD","LU0106261372.USD","SGXZ51526630.SGD","LU2552382215.SGD","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU1232071149.USD","SG9999018857.SGD","IE00BK4W5M84.HKD","LU0889565916.HKD","IE0009355771.USD","LU1988902786.USD","BK4597","LU0708995401.HKD","LU1868836757.USD","LU2756315318.SGD","BK4161","BK4139","LU1804176565.USD","IE00BJLML261.HKD","LU0058720904.USD","LU0321505868.SGD","LU0203202063.USD","LU0823434740.USD","LU0786609619.USD","LU2361044865.SGD","LU2471134523.USD","LU2756315664.SGD","LU0225284248.USD","IE0004445015.USD","IE00B1XK9C88.USD","LU1814569148.SGD","LU0345770993.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510786","title":"港股異動 | 創新藥概念股持續調整 海外利率預期反覆 2026國談收官進入結果等待期","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:08","pubTimestamp":1789096112,"startTime":"0","endTime":"0","summary":"消息面上，2026国谈现场谈判和价格协商收官，正式进入结果等待期。新版国家基本医保药品目录与商保创新药目录预计11月正式公布，2027年1月1日起统一执行。此外，能源供给风险急剧升温，10年期美债收益率攀升至近三年高位，市场定价美联储下周加息25BP的概率已升至约70%。分析人士指出，近期创新药板块的调整，主要受到海外利率预期反复、油价上行推升通胀担忧、临床风险事件扰动及资金风格轮动等因素影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","LU0072913022.USD","LU2097828474.EUR","159992","LU0149534421.HKD","06978","LU2328871848.SGD","LU1960683339.HKD","LU2488822045.USD","01801","LU0501845795.SGD","02157","LU0880133367.SGD","IE00BZ08YT58.USD","LU0244354667.USD","LU1807302812.USD","LU2242644610.SGD","LU0455707207.USD","LU1328277881.USD","KCAI","LU0067412154.USD","LU1226287875.USD","KURE","IBBQ","LU1226287792.SGD","PEVC","LU2097828557.USD","BK1589","BK1161","LU1226288170.HKD","LU1813983027.USD","MEDX","IE00BZ08YS42.EUR","LU1831875114.USD","LU1008478684.HKD","LNGR","WRTH","LU1188198961.HKD","IE0008369823.USD","01093","VXUS","09995","MCRO","LU2097828805.USD","IE0008368742.USD","LU1969619763.USD","BK4585","IE00B5MMRT66.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510878","title":"百龍創園在昆明成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:32","pubTimestamp":1789093959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","SYNB","XBI","BK4588","BK4585","GDOC","IEIH","AGNG","IBBJ","LNGR","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517543?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上，先健科技发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","KCAI","BK4585","AGNG","HART","GDOC","BK1574","09996","BK1583","01302","LGHT","PTH","LNGR","BK1600","BK1100","159883","IEIH","BK4588","MDEV","VXUS","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","09996","BK1617","BK1591","BK1583","01302","HART","BK1161","LNGR","BK1189","LU0287142896.SGD","02252","BK1571","RSPH","BK1615","BK1100","02190","02235","06826","BK1247","GDOC","BK1585","601066","BK1589","BK1600","LGHT","BK1587","BK1515","IEIH","PTH","AGNG","BK1501","00241","BK1610","BK0276","KCE","LU0173614495.USD","HK0000165453.HKD","BK1584","00853","MDEV","MEDX","BK1142","BK1222","BK1502","BK1593","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1582","BK1574","159883","HART","IEIH","PTH","LU1152091754.HKD","RSPH","BK1583","MEDX","MDEV","BK1507","AGNG","LU0880133367.SGD","LNGR","BK1185","GDOC","00152","BK1100","09996","LU1152091168.USD","LU0067412154.USD","SG9999003461.SGD","LGHT","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666751737","title":"涉IPO操縱嫌疑，香港證監會強制眼科創新藥公司撥康視雲停牌，最牛天使投資人富豪龔虹嘉是站台的基石投資者","url":"https://stock-news.laohu8.com/highlight/detail?id=2666751737","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666751737?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 08:17","pubTimestamp":1789085820,"startTime":"0","endTime":"0","summary":"停牌前，拨康视云报1.19港元，较2025年7月上市发行价10.1港元，累计蒸发约88%。这是一间成立于2015年、专注眼科创新药的临床阶段生物科技公司，四次递表才闯关成功，上市首日即告破发，如今在监管介入调查中股票停牌，前路未卜。证监会表示，调查仍在进行中，暂不作进一步评论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-09-11/doc-inirmfea2271775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCE","IPOS","BK4127","REDS","159992","MEDX","BK1574","LNGR","BK1161","FRHC","06978","IBBQ","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666511370","title":"國產創新藥新適應症密集獲批 「一藥拓多域」重塑行業成長邏輯","url":"https://stock-news.laohu8.com/highlight/detail?id=2666511370","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666511370?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 07:32","pubTimestamp":1789083145,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159992","IBBQ","BK1574","MEDX","06978","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519089","title":"國產創新藥新適應症密集獲批 「一藥拓多域」重塑行業成長邏輯","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519089?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 07:15","pubTimestamp":1789082138,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519701","title":"第七批國家組織醫用耗材集中採購開標；諾華大股東呼籲改組董事會｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519701","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519701?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 07:01","pubTimestamp":1789081313,"startTime":"0","endTime":"0","summary":"丨2026年9月11日星期五丨NO.1爱康医疗宣布提高股东股息分派占归母净利比例9月10日，爱康医疗基于对集团未来业绩及长期发展前景的信心，宣布股东股息分派及回报计划，截至2026年12月31日止财政年度，年度股息派付比例提高至不低于归母净利润的55%；截至2027年12月31日及2028年12月31日止财政年度各年，派息比例提升至不低于归母净利润的60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113871018788.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113871018788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVS","IE0002141913.USD","IE0009355771.USD","BK1161","BK1574","159938","LU0211331839.USD","BK4007","LU0320765489.SGD","BK4578","IE00B4R5TH58.HKD","PPH","09939","IE00B2B36J28.USD","LU0208291251.USD","BK4585","IE00BJJMRZ35.SGD","BK1515","IE00BFTCPJ56.SGD","MEDX","IE00BJT1NW94.SGD","BK4532","LU0070302665.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666103599","title":"媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社","url":"https://stock-news.laohu8.com/highlight/detail?id=2666103599","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666103599?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:54","pubTimestamp":1789048489,"startTime":"0","endTime":"0","summary":"媒体-礼来公司凭借GLP-1带来的意外之财，将用于推进女性健康业务——彭博社9月10日--- 来源链接： (link)https://tinyurl.com/327fb793-- 注：路透尚未核实此报道，也不对其准确性负责","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S452151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","SG9999014898.SGD","LU2471134523.USD","BK4581","IE0009355771.USD","LU1093756168.USD","SG9999015952.SGD","SG9999001176.SGD","LU1629891620.HKD","LU0689472784.USD","IE00BJLML261.HKD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU0354030438.USD","LU0964807845.USD","VHT","LU2237443549.SGD","LU1145028129.USD","LU0174119429.USD","LU0417517546.SGD","FHLC","LU0943347566.SGD","LU1291159041.SGD","LU2087625088.SGD","LU2471134796.USD","LU2236285917.USD","IE0004445015.USD","LU0006306889.USD","LU0133085943.USD","LU2361044865.SGD","LU1057294990.SGD","LU1127390331.HKD","MHIP","SGXZ31699556.SGD","LU1712237335.SGD","LU0058720904.USD","ILDR","SG9999015978.USD","LU0787776722.HKD","LU2237443895.HKD","LU0114720955.EUR","LU0256863811.USD","SG9999014906.USD","LU0096364046.USD","IE00BK4W5L77.USD","LU0471298777.SGD","LU1804176565.USD","LU1974910355.USD","LU0061475181.USD","SG9999014880.SGD","CANC","LU0289739699.SGD","LU2746668974.SGD","MEDX","LU0823434740.USD","LU0203201768.USD","LU0823416689.USD","LU1623119135.USD","PPH","SG9999015945.SGD","SGXZ57979304.SGD","LU1988902786.USD","THNR","IE0002141913.USD","JDOC","LU2264538146.SGD","LU0106261372.USD","LU2237443978.SGD","SG9999018865.SGD","LU2237438978.USD","LU1720051017.SGD","IE00BN29S564.USD","LU0820561818.USD","IE00BKDWB100.SGD","SG9999018857.SGD","LU0672654240.SGD","LU2271345857.HKD","LU0158827948.USD","LU0345770993.USD","LU2360106947.USD","LU2750360641.GBP","LU0640476718.USD","TMED","LU2237443622.USD","LU0109391861.USD","LU2089284900.SGD","XLV","IE00BJJMRX11.SGD","LU0097036916.USD","LU0320765059.SGD","LU1323610961.USD","LU2552382058.USD","LU2552382132.HKD","LU2756315664.SGD","LU2756315318.SGD","LU1868837136.USD","HRTS","LU2168564495.EUR","LU2357305700.SGD","LU0786609619.USD","LU2112291526.USD","LU0823434583.USD","LU2211815571.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0238689110.USD","LU0354030511.USD","GDOC","LU0820562030.AUD","LU0203202063.USD","LU0882574055.USD","LU0889565916.HKD","LU2111349929.HKD","LU2491050071.SGD","CURE","LU1989771016.USD","SG9999017495.SGD","LU0820561909.HKD","LU0109394709.USD","LU1917777945.USD","LU2108987350.USD","LU2471134952.CNY","LU0471298694.HKD","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","IE00B1XK9C88.USD","LU2462157665.USD","LU1551013425.SGD","RXL","LU2552382215.SGD","BK4588","LU0353189763.USD","IXJ","IE00B4JS1V06.HKD","IE00B775H168.HKD","LU2168564149.EUR","LLII","LU0210536198.USD","LU2417539215.USD","LU2750360997.AUD","LU2471134879.HKD","PJP","MEDI","LU1720051108.HKD","LU1868836914.USD","LU0708995401.HKD","LU2168564065.EUR","LU0225283273.USD","LLY","LU2468319806.SGD","BK4007","LU1061106388.HKD","LLYZ","LU0320765992.SGD","LU1069344957.HKD","BK4599","OZEM","LU2491050154.USD","BK4533","LU1064131342.USD","ELIL","LU0079474960.USD","BK4534","LU0256863902.USD","LU2461242641.AUD","LU1868836591.USD","IE00BWXC8680.SGD","IE0001KFT4U8.USD","LU2462591350.SGD","LU2491049909.HKD","LU1035775433.USD","BK4585","IE0004445239.USD","LU0266013472.USD","LU2089984988.USD","LU0122379950.USD","LU2361045086.USD","LU1548497426.USD","LU2237443465.HKD","TRUH","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU0385154629.USD","LU1868836757.USD","LU2361044949.HKD","LU2456880835.USD","LU2023251221.USD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LLYX","LU1814569148.SGD","SGXZ51526630.SGD","LU1267930730.SGD","LU2237443382.USD","LU2168563687.JPY","LU0432979614.USD","LU2028103732.USD","SG9999014914.USD","LU2168564222.USD","LU0323591593.USD","LU2023250330.USD","LU2602419157.SGD","LU2023250504.SGD","AGNG","ELIS","IHE","LU0882574139.USD","LU2746668461.USD","LU2106854487.HKD","LU2896262040.SGD","LU0466842654.USD","SG9999001176.USD","LU0353189680.USD","IE00B4R5TH58.HKD","LU1868837300.USD","LU0316494557.USD","LU0234572021.USD","LU2213496289.HKD","IE00B2B36J28.USD","LU1366192091.USD","LU1983299246.USD","LU1023059063.AUD","LU1232071149.USD","IE00BJJMRY28.SGD","WDNA","LU0158827781.USD","IE00BFSS8Q28.SGD","LU0683600562.USD","FTXH","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU0456855351.SGD","LU1979441026.SGD","IE00BK4W5M84.HKD","LU2089283258.USD","LU0198837287.USD","SG9999013999.USD","SG9999015986.USD","LU2063271972.USD","LU1093756325.SGD","LU1691799644.USD","LU0094547139.USD","IYH","IE00BKPKM429.USD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599375","title":"重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599375","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:38","pubTimestamp":1789047519,"startTime":"0","endTime":"0","summary":"艾伯维表示，服用阿托格潘特的患者平均比服用安慰剂的患者少0.8天的偏头痛天数。阿托格潘特属于针对偏头痛相关信号通路的治疗药物类别。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S45213H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU0203345920.USD","IE00BLSP4452.SGD","LU0708994859.HKD","IXJ","IE000BZT7R73.USD","LU0882574055.USD","LU0256863811.USD","BK4559","PPH","BK4588","LU2237443895.HKD","LU1236620750.USD","XLV","LU0943347566.SGD","LU0211327993.USD","LU1291159041.SGD","LU0738911758.USD","LU2129689514.USD","LU0820561909.HKD","IE000WAW04H5.SGD","JDOC","SG9999015978.USD","FHLC","ABBV","LU1934455194.USD","PJP","FTXH","LU2129689431.USD","LU0289961442.SGD","IYH","GLAM","AGNG","TRUH","LU1236620834.HKD","RXL","LU0124676726.USD","VHT","LU2089284900.SGD","LU2237443549.SGD","LU2089283258.USD","LU2125909247.SGD","LU1732799900.SGD","MEDX","LU0965509010.AUD","LU0069063385.USD","LU0057025933.USD","LU1093756168.USD","IE000MB6IJN5.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596063","title":"強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596063","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:21","pubTimestamp":1789046500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生（JNJ）美股盘前股价震荡上行，最新涨1.63%，报271.4美元。消息面上，强生周四宣布，旗下新款ACUVUE OASYS MAX双周抛复用隐形眼镜已拿到CE认证。该款产品属于ACUVUE OASYS MAX产品线的新品，可在完整14天佩戴周期内保障佩戴舒适度与清晰视力。镜片搭载OptiBlue滤光技术、TearStable锁泪技术以及一类紫外线防护功能，专门面向长时间使用电子屏幕人群的用眼需求设计。上市节奏方面，计划2026年晚些时候率先登陆部分欧洲国家；后续视各地监管审批进度，在2027-2028年进一步拓展市场。目前该产品尚未取得美国FDA批准，暂未在美国市场销售。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305910","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LU1228905037.USD","LU1244550494.USD","IE00BN8TJ469.HKD","IHE","FHLC","LU2750360997.AUD","TRUH","BK4532","LU0820562030.AUD","LU2756315318.SGD","LU2133065610.SGD","LU0124676726.USD","LU2456880835.USD","LU2505996509.AUD","RXL","LU0070217475.USD","BK4581","PJP","GDOC","LU1929549753.HKD","BMED","FTXH","BK4592","MEDX","LU1732800096.USD","LU0792757196.USD","LU1674673428.USD","LU0689626769.HKD","IE00BLSP4239.USD","IE00BGHQF631.EUR","LU0345770308.USD","LU0964807845.USD","IXJ","BK4559","LU1043141396.HKD","IE00BVYPNW00.USD","LU2750360641.GBP","IE000BZT7R73.USD","JNJ","LU1291159041.SGD","LU2756315664.SGD","VHT","LU1066053197.SGD","IE00BDGV0183.EUR","JDOC","IYH","LU0820561909.HKD","SG9999001440.SGD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":6,"totalSize":259,"code":"91000000","status":"200"}]}}